RadNet, Inc.
RDNT
Rank in Stocks
#3253
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Share Price
$69.21
Market Cap
$5.45B
Change (1 day)
0.59%
Change (1 year)
-10.04%
Country
US
Trade RadNet, Inc. (RDNT)
Category
Healthcare
P/B ratio for RadNet, Inc. (RDNT)
P/B ratio as of October 2026 TTM: 4.91
According to RadNet, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 4.91. At the end of 2023 the company had a P/B ratio of 3.51.
P/B ratio history for RadNet, Inc. from 2000 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 4.91 | -13.13% |
| 2024 | 5.65 | 61.28% |
| 2023 | 3.51 | 10.11% |
| 2022 | 3.18 | -53.90% |
| 2021 | 6.91 | 14.92% |
| 2020 | 6.01 | -9.61% |
| 2019 | 6.65 | 72.79% |
| 2018 | 3.85 | -49.98% |
| 2017 | 7.69 | 25.03% |
| 2016 | 6.15 | -25.97% |
| 2015 | 8.31 | -87.30% |
| 2014 | 65.41 | -108.01% |
| 2013 | -817.06 | 2,154.14% |
| 2012 | -36.25 | 3,122.23% |
| 2011 | -1.12 | -10.67% |
| 2010 | -1.26 | 28.12% |
| 2009 | -0.98 | -33.38% |
| 2008 | -1.48 | -70.66% |
| 2007 | -5.03 | 266.81% |
| 2006 | -1.37 | 534.92% |
| 2005 | -0.22 | -37.47% |
| 2004 | -0.35 | -0.98% |
| 2003 | -0.35 | -45.70% |
| 2002 | -0.64 | -22.79% |
| 2001 | -0.83 | 188.72% |
| 2000 | -0.29 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 4.7411 | -3.40% |
US
|
|
| 3.0143 | -38.59% |
US
|
|
| 31.051 | 532.64% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 35.77% |
US
|
